Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats. 2017

Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Egypt.

In this work, novel series of pyran, thiophene and thienopyrimidine derivatives based on 2-acetamide-thiadiazole scaffold were designed and synthesized for evaluation as selective COX-2 inhibitors in-vitro and investigated in-vivo as anti-inflammatory and analgesic agents against carrageenan-induced rat paw oedema model in irradiated rats, since its well-known that ionizing radiation plays an important role in exaggerating the inflammatory responses and in enhancing the release of inflammatory mediators in experimental animals. Toxicological studies were carried out to evaluate the ulcerogenic activity, acute toxicity and kidney and liver functions for the most potent compounds. In order to understand the binding mode of the synthesized compounds into the active site of COX-2, docking study was performed. Most of the tested compounds showed high inhibitory ability to COX-2. Among them, thiadiazole derivatives bearing thiophene and thienopyrimidine moieties were the most active derivatives, compound 26 showed extremely high selectivity index (SI) of >555.5μM which is nearly two folds better than celecoxib (>277.7μM), in addition to compounds 3, 16, 17, 21 and 26 with SI in the range of >308.6- >384.6μM. The 4-chlorothieno[2.3-d]pyrimidine derivative of thiadiazole 21 showed the highest anti-inflammatory activity in this study having 24.49% of oedema compared to celecoxib (18.61%) in addition to compounds 17 and 26 with 24.70 and 25.40% of oedema, respectively, while the thiadiazol-2-acetamide derivative 2 was the most potent analgesic compound with the highest nociceptive threshold (85.72g) very close to that of celecoxib (90.23g). These compounds showed high safety margin on gastric mucosa with no ulceration effect. Also the most active in-vivo anti-inflammatory compounds 17, 21 and 26 were found to be non-toxic in experimental rats with normal kidney and liver functions. Docking study of the synthesized compounds showed similar orientation as celecoxib within the active site of COX-2 enzyme and similar ability to emerge deeply in the additional pocket and binding with Arg513 and His90 the key amino acids responsible for selectivity.

UI MeSH Term Description Entries
D008297 Male Males
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D052246 Cyclooxygenase 2 Inhibitors A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. COX-2 Inhibitor,COX2 Inhibitor,Coxib,Cyclooxygenase 2 Inhibitor,Cyclooxygenase-2 Inhibitor,COX-2 Inhibitors,COX2 Inhibitors,Coxibs,Cyclooxygenase-2 Inhibitors,2 Inhibitor, Cyclooxygenase,COX 2 Inhibitor,COX 2 Inhibitors,Inhibitor, COX-2,Inhibitor, COX2,Inhibitor, Cyclooxygenase 2,Inhibitor, Cyclooxygenase-2,Inhibitors, COX-2,Inhibitors, COX2,Inhibitors, Cyclooxygenase 2,Inhibitors, Cyclooxygenase-2

Related Publications

Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
March 1983, Pharmacological research communications,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
November 2018, Future medicinal chemistry,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
February 2024, Future medicinal chemistry,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
January 2017, Medicinal chemistry (Shariqah (United Arab Emirates)),
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
October 2002, Dental clinics of North America,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
November 2009, Life sciences,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
October 2016, European journal of medicinal chemistry,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
April 2011, Basic & clinical pharmacology & toxicology,
Fatma A Ragab, and Helmi I Heiba, and Marwa G El-Gazzar, and Sahar M Abou-Seri, and Walaa A El-Sabbagh, and Reham M El-Hazek
October 2020, Archiv der Pharmazie,
Copied contents to your clipboard!